EMBLA Overzicht aandelen
Embla Medical hf. levert samen met haar dochterondernemingen niet-invasieve orthopedische producten in Europa, het Midden-Oosten, Afrika, Noord- en Zuid-Amerika en Azië-Pacific. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 0/6 |
Embla Medical hf. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | DKK 35.90 |
| 52 Week Hoogtepunt | DKK 36.60 |
| 52 Week Laag | DKK 26.00 |
| Bèta | 0.63 |
| 11 maand verandering | 6.21% |
| 3 maanden verandering | 16.18% |
| 1 Jaar Verandering | 31.50% |
| 33 jaar verandering | -16.02% |
| 5 jaar verandering | -28.20% |
| Verandering sinds IPO | 552.73% |
Recent nieuws en updates
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 25
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)
Oct 17Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?
Oct 02Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion
Aug 22Recent updates
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 25Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)
Oct 17Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?
Oct 02Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion
Aug 22Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 26Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)
Jul 17Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings
May 14Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09Rendement voor aandeelhouders
| EMBLA | DK Medical Equipment | DK Markt | |
|---|---|---|---|
| 7D | -0.3% | -1.2% | -3.1% |
| 1Y | 31.5% | 16.5% | 5.7% |
Rendement versus industrie: EMBLA overtrof de Danish Medical Equipment industrie, die het afgelopen jaar een rendement 16.5 % opleverde.
Rendement versus markt: EMBLA overtrof de Danish markt, die het afgelopen jaar een rendement opleverde van 5.7 %.
Prijsvolatiliteit
| EMBLA volatility | |
|---|---|
| EMBLA Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in DK Market | 10.5% |
| 10% least volatile stocks in DK Market | 2.4% |
Stabiele aandelenkoers: EMBLA heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van EMBLA is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1971 | 4,000 | Sveinn Solvason | www.emblamedical.com |
Embla Medical hf. levert, samen met haar dochterondernemingen, niet-invasieve orthopedische producten in Europa, het Midden-Oosten, Afrika, Noord- en Zuid-Amerika en Azië-Pacific. Het bedrijf is actief in drie segmenten: Prothesiologie, Bracing & Supports en Patiëntenzorg.
Embla Medical hf. Samenvatting
| EMBLA fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | DKK 15.33b |
| Inkomsten(TTM) | DKK 489.38m |
| Inkomsten(TTM) | DKK 5.95b |
31.3x
Koers/Winstverhouding2.6x
P/S-verhoudingIs EMBLA overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| EMBLA resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$840.31m |
| Kosten van inkomsten | US$319.17m |
| Brutowinst | US$521.13m |
| Overige uitgaven | US$452.07m |
| Inkomsten | US$69.07m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
Feb 05, 2025
| Winst per aandeel (EPS) | 0.16 |
| Brutomarge | 62.02% |
| Nettowinstmarge | 8.22% |
| Schuld/Eigen Vermogen Verhouding | 50.7% |
Hoe presteerde EMBLA op de lange termijn?
Bekijk historische prestaties en vergelijking